USE OF THE RETINOIDS FOR THE PREPARATION OF A MEDICAMENT DESTINED TO TREAT THE AFFECTIONS LINKED TO AN OVER-EXPRESSION OF THE GROWTH FACTOR OF THE FIBROBLASTS.

摘要

The present invention refers to the use of the retinoids in particular the anti-AP-1 retinoids for inhibiting the expression of the vascular entotelial growth factor (VEGF). the invention equally refers to the use of said retinoids for treating affections linked to an over-expression of the VEGF, especially psoriasis, Kaposi syndrome, bulbose dermatosis, tumors, etc.